Israel-based medical cannabis company InterCureLtd., chaired by former Israeli Prime Minister Ehud Barak, announced in a Wednesday filing to the Tel Aviv Stock Exchange a cannabis growing agreement with an unnamed Canadian company.

Under the agreement, the two will form a new company that will grow medical cannabis in an indoor facility in Canada.

InterCure subsidiary Canndoc will own 51% of the new company and contribute its cannabis growing experience, while the Canadian company will hold 49% and invest the resources needed to set up the facility and distribute the output.

In an interview with Calcalist, Canndoc CEO Roei Zerahia said the agreement will enable the company to quickly achieve sales in the Canadian market, without relying on export from Israel.

2019 is shaping up to be the most profitable year yet for CBD – the medicinal compound derived from marijuana. And there's still time to make a huge profit on what's quickly becoming a billion-dollar industry.

The Hemp Business Journal reports that the CBD industry, worth only $170 million in 2017, could be worth $1.1 billion by the end of next year.

And that figure could balloon to even greater heights in just the next three years. According to the Brightfield Group, the CBD industry could be worth as much as $22 billion by 2022.

That 12,000% growth potential is simply unheard of. That's why we've been telling our readers all about CBD.

People living on a quiet street in The Maples say they're tired of sharing the neighbourhood with a medical marijuana grow-op.

The house was purchased by a couple two years ago, according to land title documents, but neighbours say no one ever moved in. The owners live in another home on the same street and have only used this house to grow medical marijuana plants.

"They bought this house for a grow-op I guess," neighbour Rogelio Laoag told CBC News.

Laoag and his wife have lived in their home for about 20 years but since their neighbours' home turned into a grow-op in 2017, they haven't been able to enjoy their backyard. They say the smell of cannabis is so strong it makes them feel light-headed.

In its biggest Canadian deal to date, HelloMD is now providing health practitioner advice through the Shoppers Drug Mart medical cannabis website to streamline access for patients.

“We worked tremendously hard to be awarded this business, and being selected by Shoppers is that crowning jewel that we’ve been building towards,” says Larry Lisser, senior vice-president of business development at HelloMD.

The Medical Cannabis by Shoppers website was already up and running in Ontario and Alberta, but now it features a dedicated consultation portal operated by HelloMD.

A Winnipeg city councillor says it's time to move large scale medical marijuana grow ops out of residential neighbourhoods and into industrial areas.

Health Canada says people with a registered certificate to grow medical pot in their homes for personal use can possess up to 150 dried grams or 300 fresh grams.

There can also be up to four registrations in place for production at one location.

Coun. Ross Eadie says he's been receiving complaints about suspected medical grow ops causing odour and noise problems in two neighbourhoods. 

“A person’s right to medical cannabis does not trump people’s right to live comfortably next door,” says Eadie

Zenabis Global Inc. (TSXV: ZENA)("Zenabis" or the "Company") is pleased to announce that it has entered into a binding term sheet for a three-year supply arrangement with leading German pharmaceutical research company Farmako GmbH ("Farmako") for: (1) the supply of biosynthetically produced pure CBD isolate oil (99.9%) from Farmako to Zenabis for sale in Canada; and (2) the supply of European Union Good Manufacturing Practices ("EU GMP") certified cannabis cultivated in Zenabis' indoor facilities in Canada for sale by Farmako to the German medical market.

Healthcare experts have shown that there are hundreds of cannabinoids present in marijuana that can be used to treat different medical conditions. It’s safe to say that there are plenty of benefits and uses of CBD oil.

Here are five benefits and uses of CBD oil:

Pain Relief

One of the core benefits of CBD is that it can relieve pain. Healthcare experts and groups of researchers have discovered that chronic pain, back pain, headache and other types of pain can easily be treated using marijuana. However, it needs to use it in an appropriate dosage.

Since the legalization of cannabis, companies and stores opt to produce and sell weed products to cater to a lot of users. This massive growth of producers is observable in different states including Oregon, which leads to the oversupply of cannabis.

At present, Oregon contains pot products that will take up to seven years for users to consume it. While it looks like a positive note, cannabis growers and companies see this event as a problem.

The issuing of a license to grow cannabis would be the closest to why it overproduces. Oregon state issued over 1000 licenses to different cultivators and companies as compared to Canada’s meager 138 producers.

Interest in the marijuana industry is heating up among investors, and for good reason. Since the year began, the very first tradable cannabis exchange-traded fund, the Horizons Marijuana Life Sciences ETF, has practically tripled the returns of the broad-based S&P 500, which is having a stellar year of its own.

Already the first country in the world to legalize recreational use of marijuana, Uruguay now aims to go further by becoming the first in Latin America to export it for medicinal purposes.

It's taken a year to get to this point but in Nueva Helvecia -- 120 kilometers (75 miles) west of the capital Montevideo -- the first harvest is ready to be sent abroad.

Employees of the U.S. company Fotmer -- the only one currently licenced to export -- are cutting and drying the plant before it is exported to Europe, Canada and Australia.

In taking this step, Uruguay is joining the ranks of medicinal marijuana exporters dominated by the United Kingdom, which according to United Nations data from 2016 had cornered more than two thirds of the market.